When subsequent studies found that CellSearch results had
no influence on clinical outcomes, though, insurers lost interest in paying for it.
«While the presence of lymphocytes in tumors is often associated with better
clinical outcomes, this research adds clarity
on the diversity of T cells within the tumor environment and their
influence on ovarian cancer
outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.